What is Balance Labs Inc's earnings per share (EPS)?

Balance Labs Inc (BLNC) reported diluted earnings per share of $-1.23 for fiscal year 2025. This represents a -6050.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Balance Labs Inc Financials

BLNC

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Balance Labs Inc (BLNC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BLNC FY2025 2026-04-22

BLNC now looks less like an operating business and more like a liability-heavy shell kept alive by external financing cash.

Headline cash rose to $359K in FY2025 from $13K in FY2024, but that was not an operating recovery. Operating cash outflow of -$257K was covered by financing inflow of $603K, showing the balance sheet, not the business, funded the year.

FY2025 ended with only $398K of assets on the balance sheet against $3.8M of liabilities, leaving negative equity and very little room for error. A current ratio of 0.1x means near-term obligations tower over near-term resources, so meeting claims depends more on renegotiating or refinancing existing obligations than on a normal working-capital cycle.

What remains looks mostly like corporate overhead and debt service: FY2025 revenue was just $6K, while interest expense alone was $206K. Shares outstanding roughly doubled to 46.9M from 21.7M, suggesting outside funding has also come through dilution after the operating base had largely faded.

Financial Health Signals

Financial Profile 0/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Balance Labs Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

Balance Labs Inc has elevated debt relative to equity (D/E of -0.01), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

Balance Labs Inc's current ratio of 0.11 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6K

5Y CAGR-64.1%

10Y CAGR-17.1%

Balance Labs Inc generated $6K in revenue in fiscal year 2025.

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$-1.23

YoY-6050.0%

Balance Labs Inc earned $-1.23 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 6050.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$359K

YoY+2619.7%

5Y CAGR+129.6%

10Y CAGR+34.1%

Balance Labs Inc held $359K in cash against $25K in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

47M

YoY+116.2%

5Y CAGR+16.7%

10Y CAGR+8.6%

Balance Labs Inc had 47M shares outstanding in fiscal year 2025. This represents an increase of 116.2% from the prior year.

Margins & Returns

Gross Margin

100.0%

Balance Labs Inc's gross margin was 100.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

BLNC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$6K	N/A	N/A	$248K-60.4%	$625K-37.5%	$1.0M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$6K	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$19K+37.7%	$14K-61.6%	$36K+67.5%	$21K-29.1%	$30K-18.8%	$37K
Operating Income	N/A	-$271K-133.3%	-$116K-409.3%	-$23K-110.2%	$224K-63.4%	$613K
Interest Expense	$206K-11.0%	$231K+3.1%	$224K-3.1%	$232K-5.2%	$244K+18.7%	$206K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	-$382K+50.3%	-$768K+3.6%	-$797K-322.7%	$358K
EPS (Diluted)	$-1.23-6050.0%	$-0.020.0%	$-0.02-150.0%	$0.040.0%	$0.04+100.0%	$0.02

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$6K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	$4K-26.1%	$6K+37.1%	$4K	N/A	$5K+43.3%	$3K-21.3%	$4K
Operating Income	N/A	-$211K-166.4%	-$79K-0.5%	-$79K	N/A	-$84K-44.6%	-$58K+11.9%	-$66K
Interest Expense	N/A	$61K+7.7%	$57K-0.4%	$57K	N/A	$61K+7.9%	$57K0.0%	$57K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	-$146K-2181.3%	-$6K	N/A	-$193K-91.5%	-$101K+13.9%	-$117K
EPS (Diluted)	N/A	$-0.16-1500.0%	$-0.01	$0.00	N/A	$-0.01	$0.00	$0.00

BLNC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$398K+315.9%	$96K-56.7%	$221K-48.6%	$429K-57.7%	$1.0M-20.1%	$1.3M
Current Assets	$398K+315.9%	$96K-56.7%	$221K-48.6%	$429K-56.0%	$976K+3085.4%	$31K
Cash & Equivalents	$359K+2619.7%	$13K-88.3%	$113K-52.1%	$235K+3.4%	$228K+3940.4%	$6K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	$45K+100.0%	$23K	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.8M-27.0%	$5.2M+8.5%	$4.8M+3.8%	$4.6M+4.2%	$4.4M+14.3%	$3.9M
Current Liabilities	$3.8M-27.0%	$5.2M+8.5%	$4.8M+15.9%	$4.1M+4.4%	$3.9M+16.3%	$3.4M
Long-Term Debt	$25K	N/A	$491K+2.4%	$480K	N/A	N/A
Total Equity	-$3.4M+33.4%	-$5.1M-11.6%	-$4.5M-9.2%	-$4.2M-22.6%	-$3.4M-33.9%	-$2.5M
Retained Earnings	-$37.7M-540.0%	-$5.9M-9.9%	-$5.4M-7.7%	-$5.0M-18.3%	-$4.2M-25.8%	-$3.3M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$398K+648.0%	$53K-31.2%	$77K-11.2%	$87K-9.0%	$96K-13.4%	$110K-35.7%	$171K-9.4%	$189K
Current Assets	$398K+648.0%	$53K-31.2%	$77K-11.2%	$87K-9.0%	$96K-13.4%	$110K-35.7%	$171K-9.4%	$189K
Cash & Equivalents	$359K+7856.0%	$5K+24.5%	$4K+19.2%	$3K-77.0%	$13K-56.6%	$30K-30.6%	$44K-42.2%	$76K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.8M-56.8%	$8.7M+64.7%	$5.3M+2.6%	$5.2M0.0%	$5.2M+2.0%	$5.1M+2.7%	$4.9M+1.7%	$4.8M
Current Liabilities	$3.8M-56.8%	$8.7M+64.7%	$5.3M+2.6%	$5.2M0.0%	$5.2M+2.0%	$5.1M+2.7%	$4.9M+1.7%	$4.8M
Long-Term Debt	$25K-95.2%	$525K0.0%	$525K0.0%	$525K	N/A	N/A	$497K+0.6%	$494K
Total Equity	-$3.4M+61.1%	-$8.7M-66.1%	-$5.2M-2.9%	-$5.1M-0.1%	-$5.1M-2.4%	-$5.0M-4.1%	-$4.8M-2.2%	-$4.7M
Retained Earnings	-$37.7M-291.0%	-$9.6M-59.6%	-$6.0M-2.5%	-$5.9M-0.1%	-$5.9M-2.0%	-$5.8M-3.5%	-$5.6M-1.8%	-$5.5M

BLNC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$257K-63.6%	-$157K-28.3%	-$123K-1680.1%	$8K+113.6%	-$57K+73.9%	-$218K
Capital Expenditures	N/A	N/A	N/A	N/A	$10K	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	-$66K	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	-$204K-1063.9%	-$18K
Financing Cash Flow	$603K+948.3%	$58K	N/A	N/A	$483K+108.0%	$232K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$164K-355.4%	-$36K-2.9%	-$35K-54.1%	-$23K+49.3%	-$45K-3.0%	-$43K+37.1%	-$69K-86.3%	-$37K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$518K+1307.6%	$37K+3.7%	$36K+184.0%	$13K-54.5%	$28K	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

BLNC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	100.0%	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	-9.2%-45.2pp	35.9%-25.3pp	61.3%
Net Margin	N/A	N/A	N/A	-310.4%-182.9pp	-127.6%-163.3pp	35.8%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	-172.9%+6.2pp	-179.1%-100.5pp	-78.5%-106.7pp	28.2%
Current Ratio	0.11+0.1	0.02-0.0	0.05-0.1	0.10-0.1	0.25+0.2	0.01
Debt-to-Equity	-0.01+1.0	-1.02-0.9	-0.110.0	-0.12+1.2	-1.30+0.2	-1.52
FCF Margin	N/A	N/A	N/A	N/A	-10.6%	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	-189.2%-181.9pp	-7.4%	N/A	-174.8%-116.0pp	-58.7%+3.0pp	-61.8%
Current Ratio	0.11+0.1	0.010.0	0.010.0	0.020.0	0.020.0	0.02-0.0	0.030.0	0.04
Debt-to-Equity	-0.01+0.1	-0.06+0.0	-0.100.0	-0.10+0.9	-1.020.0	-1.02-0.9	-0.100.0	-0.11
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$3.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.11), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Crown Equity Hol CRWE

$13.1M

$18.7M

$75.7M

$7.8M

$18K

Frequently Asked Questions

What is Balance Labs Inc's annual revenue?

Balance Labs Inc (BLNC) reported $6K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How much debt does Balance Labs Inc have?

As of fiscal year 2025, Balance Labs Inc (BLNC) had $359K in cash and equivalents against $25K in long-term debt.

What is Balance Labs Inc's gross margin?

Balance Labs Inc (BLNC) had a gross margin of 100.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Balance Labs Inc's operating cash flow?

Balance Labs Inc (BLNC) generated -$257K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Balance Labs Inc's total assets?

Balance Labs Inc (BLNC) had $398K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Balance Labs Inc have outstanding?

Balance Labs Inc (BLNC) had 47M shares outstanding as of fiscal year 2025.

What is Balance Labs Inc's current ratio?

Balance Labs Inc (BLNC) had a current ratio of 0.11 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Balance Labs Inc's debt-to-equity ratio?

Balance Labs Inc (BLNC) had a debt-to-equity ratio of -0.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Balance Labs Inc's cash runway?

Based on fiscal year 2025 data, Balance Labs Inc (BLNC) had $359K in cash against an annual operating cash burn of $257K. This gives an estimated cash runway of approximately 17 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Balance Labs Inc's debt-to-equity ratio negative or unusual?

Balance Labs Inc (BLNC) has negative shareholder equity of -$3.4M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is Balance Labs Inc?

Balance Labs Inc (BLNC) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.